ALPP-targeted engineered T cells

ALPP-targeted engineered T cells · TCRCure Biopharma Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALPP-targeted engineered T cells, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors [EARLY_Phase 1]